Stock & Company Details
Aprea Therapeutics Inc $APRE
Price:
N/A
N/A
13M
$6.8M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.32
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
APRE technical indicators
Latest Aprea Therapeutics Inc (APRE) indicator readings as of 2026-10-29.
APRE's 14-day RSI is 37.1, in neutral territory. At $0.49 it is trading 34.6% below its 200-day moving average of $0.76, and below its 50-day average of $0.70. Price sits near the lower Bollinger Band ($0.45 to $0.69). ADX reads 19.5, indicating a range-bound market rather than a trend.
Overview
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Finance Bot
Ask your questions
Start by typing a question below.
